Published in Eur J Dermatol on September 14, 2010
Pleural effusion in a patient with multiple myeloma. Clin Chem (2012) 2.52
The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res (2004) 1.18
Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol (2002) 1.10
Control of melanoma cell invasion by type IV collagen. Cancer Detect Prev (2004) 1.03
Lumican inhibits angiogenesis by interfering with α2β1 receptor activity and downregulating MMP-14 expression. Thromb Res (2011) 1.03
An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. Crit Rev Oncol Hematol (2004) 1.00
Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. Proc Natl Acad Sci U S A (2013) 0.99
Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes. Cancer Lett (2009) 0.98
Identification of beta1 integrin as mediator of melanoma cell adhesion to lumican. Biochem Biophys Res Commun (2007) 0.98
{alpha}7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation. Am J Pathol (2009) 0.97
Lumican inhibits cell migration through α2β1 integrin. Exp Cell Res (2010) 0.96
Control of melanoma progression by various matrikines from basement membrane macromolecules. Crit Rev Oncol Hematol (2004) 0.96
The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration. Int J Cancer (2010) 0.95
Human collagen Krox up-regulates type I collagen expression in normal and scleroderma fibroblasts through interaction with Sp1 and Sp3 transcription factors. J Biol Chem (2007) 0.93
Chondroitin sulfate proteoglycans in tumor progression. Adv Pharmacol (2006) 0.92
Neutrophil elastase as a target in lung cancer. Anticancer Agents Med Chem (2012) 0.92
In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp Cell Res (2004) 0.92
Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14. PLoS One (2012) 0.89
Specific protein-1 is a universal regulator of UDP-glucose dehydrogenase expression: its positive involvement in transforming growth factor-beta signaling and inhibition in hypoxia. J Biol Chem (2003) 0.89
Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system. Exp Cell Res (2003) 0.89
Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med (2005) 0.88
Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. Respir Res (2008) 0.87
Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation. Biochim Biophys Acta (2008) 0.87
The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent. J Biol Chem (2003) 0.87
Lumican affects actin cytoskeletal organization in human melanoma A375 cells. Life Sci (2008) 0.86
Molecular characterization and expression analysis of a P-glycoprotein homologue in Toxoplasma gondii. Mol Biochem Parasitol (2008) 0.85
Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine. PLoS One (2012) 0.85
Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins. FEBS J (2013) 0.84
The NC1 domain of type XIX collagen inhibits in vivo melanoma growth. Mol Cancer Ther (2007) 0.83
Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression. J Invest Dermatol (2004) 0.82
Structural and antitumor properties of the YSNSG cyclopeptide derived from tumstatin. Chem Biol (2006) 0.81
Changes to cellular water and element content induced by nucleolar stress: investigation by a cryo-correlative nano-imaging approach. Cell Mol Life Sci (2013) 0.81
Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts. Mol Cell Biochem (2005) 0.80
Malondialdehyde binding to proteins dramatically alters fibroblast functions. J Cell Physiol (2002) 0.78
Ultraviolet-B irradiation induces epidermal up-regulation of heparanase expression and activity. J Photochem Photobiol B (2011) 0.78
TiCl4-promoted condensation of methyl acetoacetate, isobutyraldehyde, and indole: a theoretical and experimental study. Phys Chem Chem Phys (2015) 0.78
Changes of skin collagen orientation associated with chronological aging as probed by polarized-FTIR micro-imaging. Analyst (2014) 0.78
A cyclometallated fluorenyl Ir(iii) complex as a potential sensitiser for two-photon excited photodynamic therapy (2PE-PDT). Dalton Trans (2015) 0.78
Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer. Anticancer Res (2007) 0.78
c-Krox down-regulates the expression of UDP-glucose dehydrogenase in chondrocytes. Biochem Biophys Res Commun (2005) 0.78
Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration. FEBS Lett (2009) 0.78
Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity. Bioorg Med Chem (2008) 0.78
Deletion 2q36.2q36.3 with multiple renal cysts and severe mental retardation. Eur J Med Genet (2008) 0.78
The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells. Mol Carcinog (2013) 0.77
Rapid characterization of glycosaminoglycans using a combined approach by infrared and Raman microspectroscopies. J Pharm Sci (2011) 0.77
A new anti-tumor strategy based on in vivo tumstatin overexpression after plasmid electrotransfer in muscle. Biochem Biophys Res Commun (2013) 0.77
[Comparative analysis of immunoglobulin free light chains quantification by Freelite™ (The Binding Site) and N Latex FLC (Siemens) methods]. Ann Biol Clin (Paris) (2013) 0.77
Lumican - derived peptides inhibit melanoma cell growth and migration. PLoS One (2013) 0.77
The distribution of light elements in biological cells measured by electron probe X-ray microanalysis of cryosections. Microsc Microanal (2005) 0.76
Targeted nano analysis of water and ions using cryocorrelative light and scanning transmission electron microscopy. J Struct Biol (2012) 0.76
Investigating the relationship between changes in collagen fiber orientation during skin aging and collagen/water interactions by polarized-FTIR microimaging. Analyst (2015) 0.76
Targeted nano analysis of water and ions in the nucleus using cryo-correlative microscopy. Methods Mol Biol (2015) 0.76
Impact of carbamylation and glycation of collagen type I on migration of HT1080 human fibrosarcoma cells. Int J Oncol (2012) 0.76
Characterization of glycosaminoglycans by tandem vibrational microspectroscopy and multivariate data analysis. Methods Mol Biol (2012) 0.75
Analysis of cell dispersion and migration by video-microscopy. Methods Enzymol (2012) 0.75
The elastin peptide (VGVAPG)3 induces the 3D reorganisation of PML-NBs and SC35 speckles architecture, and accelerates proliferation of fibroblasts and melanoma cells. Histochem Cell Biol (2014) 0.75
Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging. Anal Bioanal Chem (2014) 0.75
Multiple dual-mode centrifugal partition chromatography, a semi-continuous development mode for routine laboratory-scale purifications. J Chromatogr A (2006) 0.75
Serum folate and vitamin B12: does light really matter? Clin Chem Lab Med (2014) 0.75
[Recommendations for the management of monoclonal gammopathies in biochemistry]. Ann Biol Clin (Paris) (2012) 0.75
[Proteolysis directed by the extracellular matrix]. J Soc Biol (2003) 0.75
Cytotoxic bis-3,4-dihydro-beta-carbolines and bis-beta-carbolines. J Enzyme Inhib Med Chem (2002) 0.75
In Memoriam: Professor Camille-Georges Wermuth. Eur J Med Chem (2016) 0.75
Interference of M-paraprotein in automated urea assays. Clin Chem Lab Med (2013) 0.75
Synthesis and biological evaluation of new penta- and heptacyclic indolo- and quinolinocarbazole ring systems obtained via Pd(0) catalysed reductive N-heteroannulation. Org Biomol Chem (2010) 0.75
Bifunctional polypyridyl-Ru(II) complex grafted onto gadolinium-based nanoparticles for MR-imaging and photodynamic therapy. Dalton Trans (2013) 0.75
[Biological effects of collagen I and IV peptides]. J Soc Biol (2003) 0.75
N-arylsulfonyl-2-vinyltryptamines as new 5-HT6 serotonin receptor ligands. J Enzyme Inhib Med Chem (2006) 0.75
Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s). Biochem Pharmacol (2010) 0.75
Chemical biology: contribution to molecular therapeutic innovation--a new role for chemistry? Report from the thematic symposium organized by the SCT (French Medicinal Chemistry Society), November 26th, 2013. ACS Chem Biol (2014) 0.75
Cyclopropyl-tryptamine analogues: synthesis and biological evaluation as 5-HT(6) receptor ligands. ChemMedChem (2012) 0.75
[Increased plasma C-reactive protein in a pregnant woman with multiple sclerosis: corticotherapy or not ?]. Ann Biol Clin (Paris) (2010) 0.75
[Matrikines: a new anticancer therapeutic strategy]. Biol Aujourdhui (2012) 0.75
First domino radical cyclisation/Smiles rearrangement combination. Chem Commun (Camb) (2012) 0.75